Loteprednol etabonate/tobramycin vs loteprednol etabonate vs tobramycin in infants and children with blepharoconjuncitivitis

Trial Profile

Loteprednol etabonate/tobramycin vs loteprednol etabonate vs tobramycin in infants and children with blepharoconjuncitivitis

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Feb 2012

At a glance

  • Drugs Loteprednol etabonate; Loteprednol etabonate/tobramycin; Tobramycin
  • Indications Bacterial infections; Blepharoconjunctivitis
  • Focus Adverse reactions
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 22 Feb 2012 New trial record
    • 01 Feb 2012 Results published in Pediatric Drugs.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top